Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Theseus Pharmaceuticals, Inc. (THRX)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 42,504,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Theseus Pharmaceuticals is engaged in the discovery, development and commercialization of targeted therapies for cancer patients. Co.'s development programs are designed to address drug resistance mutations in key driver oncogenes. Co.'s product candidate, THE-630, is a pan-variant inhibitor of all main classes of activating and resistance mutations of the KIT kinase for the treatment of gastrointestinal stromal tumours. Co.'s second program is focused on inhibitors of epidermal growth factor receptor (EGFR), that are active against C797S, the common EGFR mutation that causes resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,659,864 2,557,866
Total Buy Value $0 $0 $5,006,586 $9,584,210
Total People Bought 0 0 3 7
Total Buy Transactions 0 0 3 10
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 46
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Dahms Bradford D. President and CFO   •       –      –    2024-02-14 4 D $0.00 $0 D/D (8,150) 0     -
   Dukes Iain D. Director   –       •      –    2024-02-14 4 D $0.00 $0 D/D (388,324) 0     -
   Orbimed Genesis Gp Llc Director   –       •       •   2024-02-14 4 D $0.00 $0 I/I (17,713,600) 0     -
   Hayden Donald J Jr Director   –       •      –    2024-02-14 4 D $0.00 $0 D/D (10,000) 0     -
   Gordon Carl L Director   –       •       •   2024-02-14 4 D $0.00 $0 I/I (17,713,600) 0     -
   Shakespeare William See Remarks   •       –      –    2023-11-06 4 OE $0.32 $80,347 D/D 251,084 639,408     -
   Tananbaum James B. 10% Owner   –       –       •   2023-07-17 4 B $2.97 $2,079,000 I/I 700,000 1,385,825 1.5     -
   Gordon Carl L Director   –       •       •   2023-07-17 4 B $3.05 $1,463,793 I/I 479,932 650,600 2.25     -
   Orbimed Capital Gp Vii Llc Director   –       •       •   2023-07-17 4 B $3.05 $1,463,793 I/I 479,932 650,600 2.25     -
   Hayden Donald J Jr Director   –       •      –    2022-12-30 4 B $5.00 $49,489 D/D 9,900 10,000 2.39     -
   Tananbaum James B. 10% Owner   –       –       •   2022-12-29 4 B $5.00 $2,500,000 I/I 500,000 1,209,275 1.5     -
   Hayden Donald J Jr Director   –       •      –    2022-12-29 4 B $5.00 $500 D/D 100 100 2.31     -
   Dahms Bradford D. Chief Financial Officer   •       –      –    2022-11-30 4 B $6.66 $10,000 D/D 1,502 6,142 2.74     -
   Clackson Timothy P President and CEO   •       •      –    2022-11-11 4 B $6.80 $16,995 D/D 2,500 351,030 2.81     -
   Orbimed Genesis Gp Llc Director   –       •       •   2022-11-07 4 B $5.21 $1,000,320 I/I 192,000 16,734,518 2.25     -
   Gordon Carl L Director   –       •       •   2022-11-07 4 B $5.21 $1,000,320 I/I 192,000 16,734,518 2.25     -
   Tananbaum James B. 10% Owner   –       –       •   2022-06-09 3 IO $0.00 $0 I/I 0 4,294,621     -
   Orbimed Genesis Gp Llc Director   –       •       •   2022-01-21 4 B $9.97 $1,115,603 I/I 111,896 16,542,652 2.25     -
   Gordon Carl L Director   –       •       •   2022-01-21 4 B $9.97 $1,115,603 I/I 111,896 16,542,652 2.25     -
   Orbimed Genesis Gp Llc Director   –       •       •   2022-01-20 4 B $9.95 $348,250 I/I 35,000 16,430,756 2.25     -
   Gordon Carl L Director   –       •       •   2022-01-20 4 B $9.95 $348,250 I/I 35,000 16,430,756 2.25     -
   Orbimed Genesis Gp Llc Director   –       •       •   2022-01-19 4 B $9.97 $114,864 I/I 11,521 16,395,756 2.25     -
   Gordon Carl L Director   –       •       •   2022-01-19 4 B $9.97 $114,864 I/I 11,521 16,395,756 2.25     -
   Gordon Carl L Director   –       •       •   2022-01-13 4 B $9.43 $163,328 I/I 17,320 16,384,235 2.25     -
   Orbimed Genesis Gp Llc Director   –       •       •   2022-01-13 4 B $9.43 $163,328 I/I 17,320 16,384,235 2.25     -

  46 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed